FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026462690> ?p ?o ?g. }

• W2026462690 endingPage "1293" @default.
• W2026462690 startingPage "1281" @default.
• W2026462690 abstract "Objective Stimulant treatment improves impulse control among children with attention-deficit/hyperactivity disorder (ADHD). Decreased aggression often accompanies stimulant pharmacotherapy, suggesting that impulsiveness is integral to aggressive behavior in these children. However, children with high callous-unemotional (CU) traits and proactive aggression may benefit less from ADHD pharmacotherapy, because their aggressive behavior seems more purposeful and deliberate. This study’s objective was to determine whether pretreatment CU traits and proactive aggression affect treatment outcomes among aggressive children with ADHD receiving stimulant monotherapy. Method We implemented a stimulant optimization protocol with 160 children 6 to 13 years of age (mean [SD] age of 9.31 [2.02] years; 78.75% male) with ADHD, oppositional defiant or conduct disorder, and significant aggressive behavior. Family-focused behavioral intervention was provided concurrently. The primary outcome was the Retrospective Modified Overt Aggression Scale. The Antisocial Process Screening Device and the Aggression Scale, also completed by parents, measured CU traits and proactive aggression, respectively. Analyses examined moderating effects of CU traits and proactive aggression on outcomes. Results In all, 82 children (51%) experienced remission of aggressive behavior. Neither CU traits nor proactive aggression predicted remission (CU traits: odds ratio [OR] = 0.94, 95% CI = 0.80–1.11; proactive aggression, OR = 1.05, 95% CI = 0.86–1.29). Children whose overall aggression remitted showed decreases in CU traits (effect size = −0.379, 95% CI = −0.60 to −0.16) and proactive aggression (effect size = −0.463, 95% CI = −0.69 to −0.23). Conclusions Findings suggest that pretreatment CU traits and proactive aggression do not forecast worse outcomes for aggressive children with ADHD receiving optimized stimulant pharmacotherapy. With such treatment, CU traits and proactive aggression may decline alongside other behavioral improvements. Clinical trial registration information—Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder; http://clinicaltrials.gov/; NCT00228046; and Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study); http://clinicaltrials.gov/; NCT00794625. Stimulant treatment improves impulse control among children with attention-deficit/hyperactivity disorder (ADHD). Decreased aggression often accompanies stimulant pharmacotherapy, suggesting that impulsiveness is integral to aggressive behavior in these children. However, children with high callous-unemotional (CU) traits and proactive aggression may benefit less from ADHD pharmacotherapy, because their aggressive behavior seems more purposeful and deliberate. This study’s objective was to determine whether pretreatment CU traits and proactive aggression affect treatment outcomes among aggressive children with ADHD receiving stimulant monotherapy. We implemented a stimulant optimization protocol with 160 children 6 to 13 years of age (mean [SD] age of 9.31 [2.02] years; 78.75% male) with ADHD, oppositional defiant or conduct disorder, and significant aggressive behavior. Family-focused behavioral intervention was provided concurrently. The primary outcome was the Retrospective Modified Overt Aggression Scale. The Antisocial Process Screening Device and the Aggression Scale, also completed by parents, measured CU traits and proactive aggression, respectively. Analyses examined moderating effects of CU traits and proactive aggression on outcomes. In all, 82 children (51%) experienced remission of aggressive behavior. Neither CU traits nor proactive aggression predicted remission (CU traits: odds ratio [OR] = 0.94, 95% CI = 0.80–1.11; proactive aggression, OR = 1.05, 95% CI = 0.86–1.29). Children whose overall aggression remitted showed decreases in CU traits (effect size = −0.379, 95% CI = −0.60 to −0.16) and proactive aggression (effect size = −0.463, 95% CI = −0.69 to −0.23). Findings suggest that pretreatment CU traits and proactive aggression do not forecast worse outcomes for aggressive children with ADHD receiving optimized stimulant pharmacotherapy. With such treatment, CU traits and proactive aggression may decline alongside other behavioral improvements." @default.
• W2026462690 created "2016-06-24" @default.
• W2026462690 creator A5007047130 @default.
• W2026462690 creator A5012493807 @default.
• W2026462690 creator A5016786098 @default.
• W2026462690 creator A5022879927 @default.
• W2026462690 creator A5031439441 @default.
• W2026462690 creator A5058861849 @default.
• W2026462690 creator A5067193449 @default.
• W2026462690 creator A5074010287 @default.
• W2026462690 creator A5074409690 @default.
• W2026462690 creator A5076343860 @default.
• W2026462690 creator A5082157334 @default.
• W2026462690 creator A5087655699 @default.
• W2026462690 creator A5090903640 @default.
• W2026462690 date "2013-12-01" @default.
• W2026462690 modified "2023-10-07" @default.
• W2026462690 title "Callous-Unemotional Traits, Proactive Aggression, and Treatment Outcomes of Aggressive Children With Attention-Deficit/Hyperactivity Disorder" @default.
• W2026462690 cites W1963529804 @default.
• W2026462690 cites W1975554869 @default.
• W2026462690 cites W1976461935 @default.
• W2026462690 cites W1983302342 @default.
• W2026462690 cites W1989434673 @default.
• W2026462690 cites W1992630740 @default.
• W2026462690 cites W2002999583 @default.
• W2026462690 cites W2004231986 @default.
• W2026462690 cites W2005468741 @default.
• W2026462690 cites W2009154436 @default.
• W2026462690 cites W2009449617 @default.
• W2026462690 cites W2010273624 @default.
• W2026462690 cites W2010788708 @default.
• W2026462690 cites W2012047417 @default.
• W2026462690 cites W2012087754 @default.
• W2026462690 cites W2013376431 @default.
• W2026462690 cites W2016934372 @default.
• W2026462690 cites W2016945024 @default.
• W2026462690 cites W2019874967 @default.
• W2026462690 cites W2022113252 @default.
• W2026462690 cites W2022544009 @default.
• W2026462690 cites W2031384270 @default.
• W2026462690 cites W2039021607 @default.
• W2026462690 cites W2047621757 @default.
• W2026462690 cites W2047709914 @default.
• W2026462690 cites W2053751331 @default.
• W2026462690 cites W2054945284 @default.
• W2026462690 cites W2060304645 @default.
• W2026462690 cites W2063429942 @default.
• W2026462690 cites W2064260924 @default.
• W2026462690 cites W2069580171 @default.
• W2026462690 cites W2072711908 @default.
• W2026462690 cites W2073641837 @default.
• W2026462690 cites W2078725234 @default.
• W2026462690 cites W2081088104 @default.
• W2026462690 cites W2081361349 @default.
• W2026462690 cites W2081810797 @default.
• W2026462690 cites W2082248663 @default.
• W2026462690 cites W2096198637 @default.
• W2026462690 cites W2099583554 @default.
• W2026462690 cites W2104937701 @default.
• W2026462690 cites W2107573225 @default.
• W2026462690 cites W2110284624 @default.
• W2026462690 cites W2112374643 @default.
• W2026462690 cites W2115859006 @default.
• W2026462690 cites W2117399936 @default.
• W2026462690 cites W2117635888 @default.
• W2026462690 cites W2120451473 @default.
• W2026462690 cites W2121802657 @default.
• W2026462690 cites W2127863943 @default.
• W2026462690 cites W2132802915 @default.
• W2026462690 cites W2133329665 @default.
• W2026462690 cites W2133810719 @default.
• W2026462690 cites W2134455998 @default.
• W2026462690 cites W2142575168 @default.
• W2026462690 cites W2145294903 @default.
• W2026462690 cites W2146472299 @default.
• W2026462690 cites W2148978240 @default.
• W2026462690 cites W2155023983 @default.
• W2026462690 cites W2164116088 @default.
• W2026462690 cites W2166380662 @default.
• W2026462690 cites W2169091178 @default.
• W2026462690 cites W2615821452 @default.
• W2026462690 cites W4230414969 @default.
• W2026462690 cites W4239350677 @default.
• W2026462690 cites W4244617178 @default.
• W2026462690 cites W4250542743 @default.
• W2026462690 cites W4251701938 @default.
• W2026462690 doi "https://doi.org/10.1016/j.jaac.2013.08.024" @default.
• W2026462690 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4530123" @default.
• W2026462690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24290461" @default.
• W2026462690 hasPublicationYear "2013" @default.
• W2026462690 type Work @default.
• W2026462690 sameAs 2026462690 @default.
• W2026462690 citedByCount "46" @default.
• W2026462690 countsByYear W20264626902013 @default.
• W2026462690 countsByYear W20264626902014 @default.
• W2026462690 countsByYear W20264626902015 @default.
• W2026462690 countsByYear W20264626902016 @default.
• W2026462690 countsByYear W20264626902017 @default.

• next